Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $368.86M | $337.44M | 18.99% | -$31.43M |
| Metsera Inc | 3,750,662 | 3,750,662 | 0 | $106.71M | $196.27M | 11.05% | +$89.57M |
| Ocular Therapeutix, Inc.(OCUL) | 12,762,462 | 13,161,462 | +399,000 | $118.44M | $153.86M | 8.66% | +$35.42M |
| Cidara Therapeutics Inc | 639,088 | 946,788 | +307,700 | $31.13M | $90.66M | 5.10% | +$59.53M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,709 | 3,882,709 | 0 | $54.28M | $83.79M | 4.72% | +$29.51M |
| Kalvista Pharmaceuticals Inc | 6,728,985 | 6,728,985 | 0 | $76.07M | $81.96M | 4.61% | +$5.89M |
| Oruka Therapeutics, Inc.(ORKA) | 4,148,428 | 4,148,428 | 0 | $46.50M | $79.77M | 4.49% | +$33.27M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 6,596,885 | 6,596,885 | 0 | $66.96M | $79.16M | 4.46% | +$12.20M |
| Enliven Therapeutics Inc | 4,026,331 | 3,226,331 | -800,000 | $80.77M | $66.04M | 3.72% | -$14.73M |
| Cogent Biosciences, Inc.(COGT) | 4,755,411 | 4,000,000 | -755,411 | $34.14M | $57.44M | 3.23% | +$23.30M |
| CytomX Therapeutics, Inc.(CTMX) | 13,969,882 | 15,561,500 | +1,591,618 | $31.71M | $49.64M | 2.79% | +$17.93M |
| ABIVAX Société AnonymeADS(ABVX) | 1,345,780 | 576,729 | -769,051 | $10.30M | $48.96M | 2.76% | +$38.67M |
| Savara Inc.(SVRA) | 8,884,263 | 12,681,043 | +3,796,780 | $20.26M | $45.27M | 2.55% | +$25.02M |
| Spyre Therapeutics, Inc.(SYRE) | 2,685,448 | 2,685,448 | 0 | $40.20M | $45.01M | 2.53% | +$4.81M |
| Erasca, Inc.(ERAS) | 17,857,083 | 17,857,083 | 0 | $22.68M | $38.93M | 2.19% | +$16.25M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,000,000 | 960,803 | -39,197 | $18.63M | $37.81M | 2.13% | +$19.18M |
| Engene Holdings Inc COM | 5,046,414 | 5,046,414 | 0 | $18.37M | $34.47M | 1.94% | +$16.10M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 1,230,769 | +1,230,769 | $0 | $31.91M | 1.80% | +$31.91M |
| Jade Biosciences Inc | 3,220,364 | 3,220,364 | 0 | $32.17M | $27.79M | 1.56% | -$4.38M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $20.70M | $27.50M | 1.55% | +$6.80M |
| Vor Biopharma Inc.(VOR) | 0 | 499,966 | +499,966 | $0 | $24.36M | 1.37% | +$24.36M |
| Upstream Bio, Inc.(UPB) | 2,295,319 | 1,169,298 | -1,126,021 | $25.20M | $21.99M | 1.24% | -$3.21M |
| Zura Bio LimitedCL A(ZURA) | 4,631,216 | 4,631,216 | 0 | $4.86M | $20.05M | 1.13% | +$15.19M |
| Astria Therapeutics Inc | 2,457,348 | 2,457,348 | 0 | $13.17M | $17.89M | 1.01% | +$4.72M |
| Pharvaris N V COM | 2,047,620 | 674,599 | -1,373,021 | $36.04M | $16.83M | 0.95% | -$19.21M |
| Crescent Biopharma, Inc.(CBIO) | 1,387,864 | 1,387,864 | 0 | $22.40M | $16.50M | 0.93% | -$5.90M |
| Septerna, Inc.(SEPN) | 540,453 | 610,808 | +70,355 | $5.71M | $11.49M | 0.65% | +$5.78M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,379,965 | 1,379,965 | 0 | $10.39M | $8.18M | 0.46% | -$2.21M |
| Surrozen, Inc.(SRZN) | 632,931 | 632,931 | 0 | $5.66M | $8.16M | 0.46% | +$2.50M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.96M | $7.95M | 0.45% | -$15.0K |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,609,569 | 1,609,569 | 0 | $2.43M | $4.62M | 0.26% | +$2.19M |
| Tenax Therapeutics, Inc.(TENX) | 98,564 | 437,708 | +339,144 | $567.7K | $3.33M | 0.19% | +$2.76M |
| CASI Pharmaceuticals, Inc.(CASIF) | 987,259 | 987,259 | 0 | $1.16M | $1.64M | 0.09% | +$473.9K |